Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Surinabant> ?p ?o. }
Showing items 1 to 62 of
62
with 100 items per page.
- Surinabant abstract "Surinabant (SR147778) is a cannabinoid receptor type 1 antagonist developed by Sanofi-Aventis. It is being investigated as a potential treatment for nicotine addiction, to assist smoking cessation. It may also be developed as an anorectic drug to assist with weight loss, however there are already several CB1 antagonists or inverse agonists on the market or under development for this application, so surinabant is at present mainly being developed as an anti-smoking drug, with possible application in the treatment of other addictive disorders such as alcoholism. Other potential applications such as treatment of ADHD have also been proposed.".
- Surinabant atcPrefix "none".
- Surinabant casNumber "288104-79-0".
- Surinabant fdaUniiCode "SF8R9VCB0X".
- Surinabant iupacName "5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide".
- Surinabant pubchem "9849616".
- Surinabant thumbnail Surinabant.png?width=300.
- Surinabant wikiPageID "17303093".
- Surinabant wikiPageRevisionID "586875487".
- Surinabant atcPrefix "none".
- Surinabant br "1".
- Surinabant c "23".
- Surinabant casNumber "288104".
- Surinabant chembl "189676".
- Surinabant chemspiderid "8025329".
- Surinabant cl "2".
- Surinabant h "23".
- Surinabant hasPhotoCollection Surinabant.
- Surinabant inchi "1".
- Surinabant inchikey "HMXDWDSNPRNUKI-UHFFFAOYAZ".
- Surinabant iupacName "5".
- Surinabant molecularWeight "522.264".
- Surinabant n "4".
- Surinabant o "1".
- Surinabant pubchem "9849616".
- Surinabant smiles "O=Cc4nncc4CC".
- Surinabant stdinchi "1".
- Surinabant stdinchikey "HMXDWDSNPRNUKI-UHFFFAOYSA-N".
- Surinabant unii "SF8R9VCB0X".
- Surinabant verifiedfields "changed".
- Surinabant verifiedrevid "470475222".
- Surinabant watchedfields "changed".
- Surinabant subject Category:Amides.
- Surinabant subject Category:CB1_receptor_antagonists.
- Surinabant subject Category:Cannabinoids.
- Surinabant subject Category:Organobromides.
- Surinabant subject Category:Organochlorides.
- Surinabant subject Category:Piperidines.
- Surinabant subject Category:Pyrazoles.
- Surinabant type Adversary109773245.
- Surinabant type CB1ReceptorAntagonists.
- Surinabant type CausalAgent100007347.
- Surinabant type LivingThing100004258.
- Surinabant type Object100002684.
- Surinabant type Organism100004475.
- Surinabant type Person100007846.
- Surinabant type PhysicalEntity100001930.
- Surinabant type Whole100003553.
- Surinabant type YagoLegalActor.
- Surinabant type YagoLegalActorGeo.
- Surinabant type Drug.
- Surinabant type DrugProduct.
- Surinabant type FunctionalSubstance.
- Surinabant comment "Surinabant (SR147778) is a cannabinoid receptor type 1 antagonist developed by Sanofi-Aventis. It is being investigated as a potential treatment for nicotine addiction, to assist smoking cessation.".
- Surinabant label "Surinabant".
- Surinabant sameAs m.043mr33.
- Surinabant sameAs Q7646304.
- Surinabant sameAs Q7646304.
- Surinabant sameAs Surinabant.
- Surinabant wasDerivedFrom Surinabant?oldid=586875487.
- Surinabant depiction Surinabant.png.
- Surinabant isPrimaryTopicOf Surinabant.